The Medical Minute: Stress tests - echo vs. nuclear
February 8, 2012 By Claude Fanelli in Other
Your health care provider has ordered a stress test for your heart. No problem, you think; you’ve seen people walk on treadmills before. In fact, you used the one in your basement a few times, a couple of years ago. Then, you look at the request and see that you are going to have a pharmacologic nuclear stress test. So, what exactly did your physician order?
While the most frequent reasons for stress testing remain the same -- diagnosis of coronary artery disease (CAD), risk stratification of those with known CAD; diagnosis of valvular heart disease; or diagnosis of arrhythmia—the procedure itself has evolved considerably over the years. The basic stress test involves walking on a treadmill while your electrocardiogram (EKG) is continuously monitored for changes that may indicate a blocked artery to the heart. However, there are options if you are unable to walk on a treadmill or if your EKG is already abnormal at rest. The existing options include: imaging stress tests -- echocardiographic or nuclear -- and pharmacologic stress tests -- adenosine and dobutamine.
There are a variety of situations in which the EKG alone cannot be used to monitor stress tests, such as baseline abnormalities or the potential for changes that look like but are not due to blockages. These situations include pacemakers, bundle branch block, enlarged heart and various medications. In these situations, imaging with either echocardiography (ultrasound) or nuclear agents is used.
In echo stress testing, the heart is imaged with ultrasound at rest and then again immediately following stress. With stress the heart beats faster and more vigorously and therefore, more blood flow is required. If there is a blockage severe enough to limit blood flow, that area of the heart will not work as well as compared to normal areas.
Nuclear imaging involves the use of agents (thallium or technetium, for example) that are taken up by heart muscle cells and a gamma camera to detect the radioactivity. For this to occur, the cells must be living, and there must be blood flow. Scar tissue, as from a previous heart attack, is not living and, therefore, takes up no radioisotopes. Where there are significant blockages, blood flow cannot adequately increase, and there will be less radioisotope uptake in those areas as compared to normal.
A significant number of patients are unable to adequately walk on a treadmill, usually due to age-related or orthopedic issues. In these, the heart can be stressed using adenosine or dobutamine. These pharmacologic stress tests are always coupled with an imaging modality because their effects may not be detectable with an EKG alone.
Adenosine is a potent agent that dilates the blood vessels and increases blood flow. Where there is a blockage, the vessel is unable to dilate as much as in normal vessels, so there will be less increase in blood flow and less detected radiation.
Dobutamine, on the other hand, truly simulates exercise by increasing heart rate and blood pressure. In dobutamine stress echo, your doctor will see a lack of the expected increase in heart muscle function where there is a blockage that limits blood flow.
While both echo stress tests and nuclear stress tests ultimately can provide the same information, there are differences and advantages and disadvantages between the two.
Advantages of echo stress test:
-- Faster
-- Less costly
-- Additional information
-- No radiation
-- Results are immediately available
Advantages of nuclear stress test:
-- Rarely unable to obtain adequate images
-- Less difficult to interpret in those with baseline abnormalities of heart function
Which is chosen by your health care provider ultimately depends on your unique situation, the information needed and the local expertise with the various tests.
Provided by
Pennsylvania State University
-
Taking the stress out of choosing the right stress test
Oct 12, 2007 |
not rated yet |
0
-
Heart ultrasound helps determine risk of heart attack, death in HIV patients
Jul 12, 2011 |
not rated yet |
0
-
Regadenoson is safe, effective for use in heart transplant patients
Mar 14, 2010 |
not rated yet |
0
-
Nuclear stress test can detect more than blockages
Jul 14, 2008 |
not rated yet |
0
-
Mini 'stress tests' could help condition heart to survive major attack
Jan 07, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...
Other
10 minutes ago |
not rated yet |
0
Plastic realistic: Medical students to use plastinated human bodies for anatomy learning
Nanyang Technological University's (NTU) new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.
Other
9 hours ago |
not rated yet |
0
Survey points out deficiencies in addictions training for medical residents
A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) – one of the nation's leading teaching hospitals – found that more than half rated the training they had received in addiction and other ...
Other
May 22, 2013 |
5 / 5 (1) |
0
Early use of tracheostomy for mechanically ventilated patients not associated with improved survival
For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...
Other
May 21, 2013 |
not rated yet |
0
Decisions to forgo life support may depend heavily on the ICU where patients are treated
The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...
Other
May 21, 2013 |
not rated yet |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
WHO: Scientific red tape mars efforts vs. virus
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...
Research identifies a way to make cancer cells more responsive to chemotherapy
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Mayo Clinic genomic analysis lends insight to prostate cancer
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Shortage of key drug hampering U.S. efforts to control TB, report says
(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.